Phase 1 study of WT-1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia

Trial Profile

Phase 1 study of WT-1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2015

At a glance

  • Drugs Galinpepimut S (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Dec 2015 New trial record
    • 30 Nov 2015 Positive data were reported at the International WT1 Conference, as per Sellas Life Sciences media release.
    • 30 Nov 2015 Results published in Sellas Life Sciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top